Endava Admits Unreliable Financials, Replaces CEO/CFO, Restatements Pending – Governance Crisis Threatens Valuation

What happened

Endava plc disclosed in an SEC filing on October 28, 2026 that accounting for certain customer agreements was incorrect, that its financial statements are unreliable, and that restatements are pending, while simultaneously announcing the departure of CEO John Cotterell (replaced by an interim CEO) and CFO Mark Thurston three days prior, along with the resignation of General Counsel Rohit Bhoothalingam. That disclosure directly contradicts the company's previous assertion in its fiscal 2025 20-F that internal control over financial reporting was effective, raising questions about the board's oversight and the integrity of reported results amid an already weak operating backdrop (revenue contraction, compressed margins, and unvalidated AI pricing). The news follows a period in which Endava had already lost investor confidence due to repeated guidance misses and an AI pivot that had yet to prove its economics, and the stock had already fallen from over $20 to around $4.50 before this revelation. With restatements pending, investors cannot rely on historical financials or management's forward guidance, and the company's ability to access capital or maintain client relationships may be further impaired. This governance crisis invalidates the previous deep value thesis, which was based on observable margin stabilization and revenue inflection, and instead requires a complete reassessment of the company's viability and asset values.

Implication

If the restatement reveals material revenue overstatement or fraudulent contracts, Endava's equity could be significantly impaired; any long-term investment case must await audited restated financials, a new management team, and evidence of underlying business stability, which could take quarters.

Thesis delta

The prior WAIT thesis was conditionally positive, hinging on observable margin and revenue stabilization. That thesis is now broken because reported financials are unreliable, and management credibility is destroyed. The investment case shifts from turnaround speculation to forensic analysis of the restatement, with a base case that equity value may be substantially lower or zero if contracts lack economic substance. Until audited restated financials and a new management team are in place, the appropriate stance is to exit or avoid the stock.